Prevalence and Persistence of Varicella Antibodies in Previously Immunized Children and Youth With Perinatal HIV-1 Infection
Author(s) -
Murli Purswani,
Brad Karalius,
TzyJyun Yao,
D. Scott Schmid,
Sandra Burchett,
George K. Siberry,
Kunjal Patel,
Russell B. Van Dyke,
Ram Yogev
Publication year - 2015
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/civ734
Subject(s) - medicine , persistence (discontinuity) , antibody , immunology , virology , human immunodeficiency virus (hiv) , pediatrics , engineering , geotechnical engineering
Two doses of live-attenuated varicella-zoster vaccine are recommended for human immunodeficiency virus 1 (HIV-1)-infected children with CD4% ≥ 15%. We determined the prevalence and persistence of antibody in immunized children with perinatal HIV (PHIV) and their association with number of vaccinations, combination antiretroviral therapy (cART), and HIV status.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom